Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by deploying Evinova’s AI-native platform in an effort to speed up…

Preclinical CRO RoukenBio has inked a partnership with Connecticut-based biologics discovery specialist AVS Bio that aims to leverage each others'…

Irish CRO Icon has revoked its 2025 financial guidance and launched an internal investigation after being made aware of possible…

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in…

Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and…

British drug discoverer Sygnature Discovery plans to lay off 60 employees in the U.K. and an undisclosed number of staffers…

Worldwide Clinical Trials is expanding its horizons with the acquisition of Catalyst Clinical Research, a specialist oncology organization with a…

Charles River Laboratories has struck a $510 million deal to buy a nonhuman primate (NHP) provider, furthering efforts to strengthen its…

James Foster’s legendary half-century run at Charles River Laboratories is coming to an end. After more than 30 years as…

North Carolina-based CRO WEP Clinical is bolstering its global offerings with the acquisition of European CRO Siron Clinical. Siron, headquartered…